Chemotherapy of pancreatic carcinoma
- 1 December 1984
- journal article
- Published by Wiley in World Journal of Surgery
- Vol. 8 (6) , 935-939
- https://doi.org/10.1007/bf01656035
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreasCancer, 1980
- Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.1980
- Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-d in advanced measurable pancreatic carcinoma.A gastrointestinal tumor study group reportCancer, 1978
- Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancerCancer, 1978
- Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.1976
- 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.1975
- The integration of chemotherapy into a combined modality approach for cancer treatmentCancer Treatment Reviews, 1975
- Streptozotocin therapy in 22 cancer patientsCancer, 1975
- Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.1972
- COMBINED 5-FLUOROURACIL AND SUPERVOLTAGE RADIATION THERAPY OF LOCALLY UNRESECTABLE GASTROINTESTINAL CANCERThe Lancet, 1969